BRINTELLIX 20 MG Israel - Inggris - Ministry of Health

brintellix 20 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 20 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 20 MG Israel - Inggris - Ministry of Health

brintellix 20 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 20 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 5 MG Israel - Inggris - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 5 MG Israel - Inggris - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

ABILIFY  MAINTENA 300 MG Israel - Inggris - Ministry of Health

abilify maintena 300 mg

lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

ABILIFY  MAINTENA 400 MG Israel - Inggris - Ministry of Health

abilify maintena 400 mg

lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

SELINCRO 18 MG Israel - Inggris - Ministry of Health

selincro 18 mg

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

SELINCRO 18 MG Israel - Inggris - Ministry of Health

selincro 18 mg

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

REXULTI  0.5 MG Israel - Inggris - Ministry of Health

rexulti 0.5 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 0.5 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.

REXULTI  1 MG Israel - Inggris - Ministry of Health

rexulti 1 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 1 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.